Tests
NGS testing
Next-generation sequencing
Tests that examine multiple genetic changes to help inform treatment options.
Sources checked · Introductory guide
On this page
What can it tell you?
Genomic biomarker testing can inform targeted therapy or clinical trial options. NGS can examine many genes at once.[1]
Understanding the limits
Finding a change does not guarantee an available or effective treatment. Tumor testing can differ from testing for inherited cancer risk.[1]
Questions for your care team
- Could this test change my treatment options?
- Will I need another sample or genetic counseling?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.
Related entries
Small cell lung cancer
TestsBiopsy and pathology report
Genes & biomarkersBRCA1 and BRCA2 variants
Genes & biomarkersKRAS variants
Genes & biomarkersNRAS variants
Genes & biomarkersEGFR variants
Genes & biomarkersALK fusions and rearrangements
Genes & biomarkersROS1 fusions
Genes & biomarkersBRAF variants
Genes & biomarkersHER2 / ERBB2 results
Genes & biomarkersPIK3CA variants
Genes & biomarkersESR1 variants
Genes & biomarkersRET fusions and variants
Genes & biomarkersMET exon 14 and amplification
Genes & biomarkersNTRK1 / NTRK2 / NTRK3 fusions
Genes & biomarkersFGFR2 fusions and rearrangements
Genes & biomarkersFGFR3 variants
Genes & biomarkersIDH1 variants
Genes & biomarkersFLT3 variants
Genes & biomarkersBCR::ABL1 fusion
Genes & biomarkersKIT variants
Genes & biomarkersPDGFRA variants
Genes & biomarkersUnderstanding gene and biomarker results